ASX:HSO - Healthscope Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
A$2.46 +0.01 (+0.41 %)
(As of 05/20/2019 04:00 PM ET)
Previous CloseA$2.45
Today's RangeA$2.46 - A$2.47
52-Week RangeA$1.77 - A$2.50
Volume9.14 million shs
Average Volume6.04 million shs
Market Capitalization$4.28 billion
P/E Ratio17.32
Dividend Yield2.87%
Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.

Receive HSO News and Ratings via Email

Sign-up to receive the latest news and ratings for HSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospitals



Sales & Book Value

Annual Sales$2.38 billion
Cash FlowA$0.06 per share
Book ValueA$1.46 per share



Outstanding Shares1,741,159,936
Market Cap$4.28 billion
Next Earnings DateN/A
OptionableNot Optionable

Healthscope (ASX:HSO) Frequently Asked Questions

What is Healthscope's stock symbol?

Healthscope trades on the ASX under the ticker symbol "HSO."

How often does Healthscope pay dividends? What is the dividend yield for Healthscope?

Healthscope declared a Interim dividend on Friday, February 15th. Stockholders of record on Tuesday, March 26th will be given a dividend of 0.035 per share on Tuesday, March 26th. This represents a dividend yield of 1.42%. The ex-dividend date is Monday, March 4th. View Healthscope's Dividend History.

Has Healthscope been receiving favorable news coverage?

Media coverage about HSO stock has trended somewhat negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Healthscope earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term.

Who are some of Healthscope's key competitors?

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include E Tracs Ubs Blomberg Cmci Energy Etn (UBN), Primary Health Care (PRY) and Fortescue Metals Group (FMG).

Who are Healthscope's key executives?

Healthscope's management team includes the folowing people:
  • Mr. Gordon Scott Ballantyne, MD, CEO & Director (Age 54)
  • Mr. Michael Sammells, Chief Financial Officer
  • Mr. Mark Briscoe, Gen. Mang. of Operations
  • Mr. David Shirer, Gen. Mang. of Investor Relations
  • Ms. Ingrid A. Player, Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec. (Age 46)

What is Healthscope's stock price today?

One share of HSO stock can currently be purchased for approximately A$2.46.

How big of a company is Healthscope?

Healthscope has a market capitalization of $4.28 billion and generates $2.38 billion in revenue each year. Healthscope employs 17,100 workers across the globe.

What is Healthscope's official website?

The official website for Healthscope is

How can I contact Healthscope?

Healthscope's mailing address is Level 1, 312 St. Kilda Road, MELBOURNE, VIC 3001, Australia. The company can be reached via phone at +61-3-99267500.

MarketBeat Community Rating for Healthscope (ASX HSO)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  99
MarketBeat's community ratings are surveys of what our community members think about Healthscope and other stocks. Vote "Outperform" if you believe HSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/20/2019 by Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel